IDiyas

For the Inventor, By the Inventor

Sean Michael Kerwin

Round Rock, TX, United States of America

Sean Michael Kerwin

LinkedIn
USPTO Granted Patents = 16

Average Co-Inventor Count = 3.3

ph-index = 8

Forward Citations = 439(Granted Patents)


Company Filing History:

goldMedal9 out of 5,444 
 
University of Texas System
 patents
silverMedal4 out of 297 
 
Research Development Foundation
 patents
bronzeMedal1 out of 723 
 
Zymogenetics, Inc.
 patents
4. 1 out of 28 
 
Osteoscreen, Inc.
 patents
5. 1 out of 1 
 
Ctrc Research Foundation Board of Regents
 patent
6. 1 out of 5 
 
Ctrc Research Foundation
 patents
7. 3 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 1999-2007

Loading Chart...
16 patents (USPTO):Explore Patents
1. 7294643 - UK-1 analogues: methods of preparation and use (2007-11-13),
2. 6908948 - DNA-cleaving antitumor agents (2005-06-21),
3. 6720344 - Methods and compositions for stimulating osteoblast proliferation or treating malignant cell proliferation and methods for selecting osteoblast proliferation stimulants (2004-04-13),
4. 6689887 - Inhibition of human telomerase by a G-quadruplex-interaction compound (2004-02-10),
5. 6686345 - DNA-cleaving antitumor agents (2004-02-03),
6. 6649631 - Compositions and methods for treating bone deficit conditions (2003-11-18),
7. 6623930 - Inhibition of human telomerase by a G-quadruplex-interaction compound (2003-09-23),
8. 6593306 - Methods for modulation and inhibition of telomerase (2003-07-15),
9. 6562969 - Ricin inhibitors and methods for use thereof (2003-05-13),
10. 6528517 - Synthesis of quinobenzoxazine analogues with topoisomerase II and quadruplex interactions for use as antineoplastic agents (2003-03-04),
11. 6297284 - DNA-cleaving antitumor agents (2001-10-02),
12. 6177280 - Ricin inhibitors and methods for use thereof (2001-01-23),
13. 6156763 - Inhibition of human telomerase by a g-quadruplex-interaction compound (2000-12-05),
14. 6054442 - Methods and compositions for modulation and inhibition of telomerase in (2000-04-25),
15. 6004939 - Methods for modulation and inhibition of telomerase (1999-12-21),

Title: Sean Michael Kerwin: Pioneering Innovator in Cancer Research

Introduction:

Sean Michael Kerwin, a remarkable inventor based in Round Rock, TX, has made significant contributions to the world of innovation with his inventive mindset and dedication to excellence. His groundbreaking inventions are shaping the future of cancer research and treatment.

Latest Patents:

Among his 16 patents, Sean Michael Kerwin's latest patents stand out for their impact on the field of oncology. One of his inventions includes UK-1 analogues, which have shown promising results in targeting cancer cells selectively. Additionally, his DNA-cleaving antitumor agents have opened new possibilities for advanced cancer treatments.

Career Highlights:

Throughout his career, Sean Michael Kerwin has demonstrated a strong focus on advancing cancer research. His work at the University of Texas System and Research Development Foundation has led to numerous breakthroughs in the field of oncology, setting new standards for innovative cancer treatments.

Collaborations:

Sean Michael Kerwin has worked closely with esteemed colleagues such as Laurence H Hurley and Miguel Salazar. Together, they have combined their expertise to push the boundaries of cancer research and develop novel solutions for combating this complex disease.

Conclusion:

Sean Michael Kerwin's relentless pursuit of excellence in innovation has established him as a visionary pioneer in the field of cancer research. His inventive spirit and collaborative efforts continue to drive towards creating transformative inventions that have the potential to revolutionize the landscape of oncology and benefit countless lives worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…